Landos Biopharma, Inc. - stock earnings
LABP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -5.9 million USD | ? USD |
| 2023Q2 | -3.9 million USD | ? USD |
| 2023Q1 | -5.6 million USD | ? USD |
| 2022Q4 | -3.9 million USD | ? USD |
| 2022Q3 | -8.0 million USD | ? USD |
| 2022Q2 | -11.3 million USD | ? USD |
| 2022Q1 | -14.8 million USD | ? USD |
| 2021Q4 | -20.1 million USD | -18.0 million USD |
| 2021Q3 | -12.6 million USD | ? USD |
| 2021Q2 | 4.1 million USD | 18.0 million USD |
| 2021Q1 | -9.8 million USD | ? USD |
| 2020Q4 | -11.3 million USD | ? USD |
| 2020Q3 | -8.2 million USD | ? USD |
| 2020Q2 | -4.8 million USD | ? USD |
| 2020Q1 | -5.8 million USD | ? USD |
| 2019Q4 | -3.5 million USD | ? USD |
LABP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.0 million USD | ? USD |
| 2022 | -38.0 million USD | ? USD |
| 2021 | -38.2 million USD | 18.0 million USD |
| 2020 | -30.1 million USD | 18.0 million USD |
| 2019 | -13.9 million USD | ? USD |
| 2018 | -6.0 million USD | ? USD |
LABP
Price: $22.24
52 week price:
Earnings Per Share: -3.50 USD
P/E Ratio: -1.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 125700
Market Capitalization: 69.4 million